Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: A retrospective cohort study

Objectives: To investigate the effectiveness of intravenous immunoglobulin (IVIG) as treatment for COVID-19 in immunocompromised patients. Methods: This retrospective study investigated outcomes for immunocompromised, vaccine non-responsive, patients that between September 2022 and April 2023 receiv...

Full description

Bibliographic Details

Main Authors:	Remigius Gröning, Jonatan Walde, Clas Ahlm, Mattias N.E. Forsell, Johan Normark, Johan Rasmuson
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2024-07-01
Series:	International Journal of Infectious Diseases
Subjects:	SARS-CoV-2 COVID-19 Immunocompromised Intravenous immunoglobulin Humoral immunity
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971224001176
Tags:	Add Tag No Tags, Be the first to tag this record!